James Bristol A.'s Insider Trades & SAST Disclosures
James Bristol A.'s most recent trade in Eterna Therapeutics Inc was a trade of 72,074 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Bristol A..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 72,074 | 72,074 | - | - | Stock Option (Right to buy) | |
| Erasca Inc | James Bristol A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 45,678 | 45,678 | - | - | Stock Option (right to buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Eterna Therapeutics Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 124,525 | 124,525 | - | - | Stock Option (Right to buy) | |
| Erasca Inc | James Bristol A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,747 | 62,747 | - | - | Stock Option (right to buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | James A. Bristol | Director | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 21 Dec 2022 | 20,000 | 20,000 | - | 4.1 | 82,800 | Common Stock |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges